Cardinal Health Q4 Preview: Accelerating Autoimmune, Urology And Oncology, Buy

Group 1 - Cardinal Health, Inc. (NYSE: CAH) is a distributor of pharmaceuticals and medical/laboratory products [1] - The company is investing in its distribution capabilities for fast-growing segments including autoimmune, urology, and oncology [1] - There has been a turnaround in its Global Medical Products segment [1]